PHARMACEUTICAL INDUSTRY

POLITICS

Here's How Congress Is Helping Big Pharma Keep Drug Prices High

IMPACT

Mom Without Memories

Adam Grossman, Contributor Co-Founder of Give To Cure, the first nonprofit to accelerate ...

POLITICS

Where Bernie Sanders' Health Care Crusade Might Go From Here

BUSINESS

We Stopped Pfizer's Tax Dodge, Now Let's End the Buybacks

William Lazonick, Contributor Director, University of Massachusetts Center for Industrial Co...

POLITICS

Rx for Outrageous Drug Prices: Heal Our Democracy

Robert Weissman, Contributor President, Public Citizen

BUSINESS

Inside Big Pharma's Campaign To Put Us All To Sleep.

EDUCATION

The Old Testament Pool Player

Mitch Ditkoff, Contributor President, Idea Champions

POLITICS

Cancer Patient Lays Bare the Danger of TPP and the "Pharma Bro" Problem

Lori Wallach, Contributor Director, Public Citizen's Global Trade Watch

POLITICS

Donald Trump Reportedly Says He's With Hillary Clinton, Bernie Sanders On Drug Pricing

POLITICS

Pharmaceutical Companies Drive the Heroin Epidemic

Alex Lawson, Contributor Executive director, Social Security Works

BUSINESS

Holding Drug Companies Accountable for Drug Prices

Ezekiel J. Emanuel, M.D., Ph.D., Contributor Chair of the Department of Medical Ethics and Health Policy at...

POLITICS

This Meeting Between the FDA and Medical Industry Should Never Have Happened

Michael Carome, M.D., Contributor Director of Public Citizen's Health Research Group.

HEALTHY LIVING

After 60 Years, The Surgeon General’s Address On Addiction Is A Long Time Coming

By Rebecca Flood, MHS, LCDC, CADCII, BRI II, Contributor
Rebecca Flood is CEO of New Directions for Women, an exclusive...

HEALTHY LIVING

The Complexity And Challenges Of Pharmaceuticals

By Lenny Sanicola, Contributor
Senior Practice Leader, WorldatWork
www.pixabay.com

HEALTHY LIVING

Why Tom Price's Biotech Stock Has Medical Ethicists Worried

By Sarah DiGiulio
Alex Wong via Getty Images

CRIME

City Sues Pharma Company Over OxyContin Black Market

By Mary Papenfuss
Rick Eglinton via Getty Images

POLITICS

Should Trump Nominee Tom Price Be In Jail For Insider Trading?

By Nancy Altman, Contributor
President, Social Security Works

POLITICS

Tom Price Just Contradicted Trump Team's Defense Of His Questionable Stock Trades

By Paul Blumenthal
Alex Wong via Getty Images

HEALTHY LIVING

Despite Rising Rates Of Depression, It's Doubtful We'll See New Drugs

Savushkin via Getty Images

POLITICS

Trump’s HHS Nominee Got A Sweetheart Deal From A Foreign Biotech Firm

By Kaiser Health News
Jonathan Ernst / Reuters

HEALTHY LIVING

CVS Boosts Access To EpiPen Rival That's Only 17 Percent The Cost

By Anna Almendrala
Serenethos via Getty Images

POLITICS

Cory Booker And A Bunch Of Democrats Prove Trump Right On Big Pharma

By Zach Carter and Ryan Grim
SAUL LOEB via Getty Images

POLITICS

Bernie Sanders: Donald Trump Is Right About Big Pharma

By Zach Carter and Erin Schumaker
Arun Nevader via Getty Images

POLITICS

Trump’s Health Secretary Nominee Sought Special Treatment For Industry Donors

By Kaiser Health News, Contributor
A national health policy news service that is part of the nonp...
Jonathan Ernst / Reuters

HEALTHY LIVING

Why New Drug Approvals Are At A Six-Year Low In The U.S.

Photography by ZhangXun via Getty Images

HEALTHY LIVING

Mylan Launches EpiPen Generic At $300 Per Two-Pack

Jim Bourg / Reuters

POLITICS

Donald Trump Vows To Reduce Drug Prices, Doesn't Say How

TIMOTHY A. CLARY via Getty Images

HEALTHY LIVING

How The Trump Administration Could Hurt The Pharmaceutical Industry

Mike Segar / Reuters

POLITICS

Mylan Is Proof That Big Business Picks America's Pockets While Gov't Mostly Looks Away

By Michael Winship, Contributor
Senior writer, BillMoyers.com. Former senior writing fellow, D...

FIFTY

How To Pay For Healthy Longevity

By Michael Hodin, Contributor
CEO, Global Coalition on Aging

SCIENCE

The Perils Of Polypharmacy

By Allen Frances, Contributor
Professor Emeritus, Duke University

HEALTHY LIVING

Hepatitis C Is Killing Americans in Record Numbers While Patients Cannot Access Life Saving Medicine

By David Rein, Contributor
Economist, research scientist and policy analyst
Subscribe to The Morning Email.
Wake up to the day's most important news.
Pages: 1 2 3 4 5 6